Re7 Labs

Re7 Labs is a multi-chain DeFi yield curator / vault manager, not a single monolithic AMM or money market. Identification

• Name: Re7 Labs.
• Website: re7labs.xyz (plus subdomains like starknet.re7labs.xyz for chain-specific frontends).
• Docs: No separate developer docs portal was found; technical detail is mainly via blogs/partner writeups (Starknet blog, Pyth blog, Portals.fi/Hindenrank analyses). *Not verifiable as of 2026-08-29* whether formal docs exist under another subdomain.
• Category: Risk curator / yield vault manager operating ERC‑4626-style strategies across lending and LP protocols (Morpho, Mellow, Silo, Gearbox, etc.). Some products are branded as ALMM (automated liquidity market maker) on Starknet.
• Launch date: Re7 (firm) is described as “active since 2021” in an April 22, 2026 press release. *Protocol-level launch date per chain is not verifiable as of 2026-08-29*. Chains and TVL footprint Independent aggregators list Re7 Labs as deployed across 12–15 chains, including the ones you flagged:
• DefiLlama preview: Ethereum, World Chain, Avalanche, Plume Mainnet, Plasma, Base, Starknet, Linea, BSC with most TVL on Ethereum and World Chain.
• Bathymark and MrDeFi similarly classify Re7 Labs as a “Risk Curators” protocol across World Chain, Avalanche, Plasma, Binance, Starknet, Ethereum, and more, with ~$80–81M liquidity. Given your chain list (World Chain, Avalanche, Plasma, Ethereum, Starknet, Binance, Plume, Linea), these are all explicitly supported in at least one independent dataset. Exact per-chain TVL distribution is aggregator-only and *Not verifiable as of 2026-08-29* on-chain under the constraints. Native token No credible independent source indicates a Re7 protocol token; Re7 typically curates vaults denominated in ETH, BTC, USDT, USD1, LSTs, and restaking tokens rather than issuing a native governance token. Any token-like tickers (e.g., mRe7YIELD, mRE7BTC) refer to strategy tokens or Morpho/Midas vault share tokens, not a canonical native asset. Main contracts and verification status Under current tool restrictions, specific contract addresses and explorer verification status are Not verifiable as of 2026-08-29. Public materials consistently describe Re7 as operating ERC‑4626 vaults on partner protocols (Morpho, Mellow, Gearbox, etc.), meaning user funds are held in those vault contracts, not a single Re7-owned core contract. Fork lineage and code provenance
• Available independent coverage frames Re7 as a curator/operator on existing protocols (Morpho, Mellow, Silo, Gearbox, Ekubo) rather than a fork of a prior DeFi protocol.
• The Starknet ALMM is described as purpose-built for Ekubo pools; no evidence it is a direct fork of another on-chain product.
• No public audit reports specifically for Re7-authored contracts (ALMM or vault implementations) were located in independent sources; *Not verifiable as of 2026-08-29* whether any audits exist.
• No record was found of malicious modifications in forks associated with Re7 Labs; coverage from Starknet, Pyth, Portals.fi and media portrays them as an institutional vault curator rather than a fork-based protocol exploiter. Given the lack of on-chain access in this run, any unreferenced contract- or token-level detail would be speculative, so it is intentionally omitted.

Re7 Labs appears to have a real product surface, but the evidence found is stronger for a curated vault/strategy interface than for a full standalone consumer app. Public references show live deposit and withdrawal flows in Wallet’s DeFi Account for a Re7 Labs USDT earn product, including a minimum deposit of 1 USDT and withdrawals that can take up to 14 days, which indicates an operational yield product rather than a static landing page. The Re7 Labs site itself describes research and risk tooling, and its blog/X references point to specific strategy pages and integrations, which also suggests active product distribution rather than a template-only site. That said, a few maturity checks remain only partially verifiable from the available web evidence. The main site evidence did not confirm an open public API, and no authoritative API documentation was found; therefore, open API status is Not verifiable as of 2026-08-29. Similarly, broken-link prevalence, fake metrics, and template-origin signs were not systematically verifiable from the available sources; there were no clear red flags in the retrieved material, but this is not enough to rule them out. The strongest visible product signal is the Wallet-integrated earn flow, while the Re7Labs website itself reads more like a corporate/research portal than a self-service app. On balance: real protocol/strategy operator, some live UX and deposit/withdraw functionality, but no verified open API and no full evidence of a mature standalone portal from the sources reviewed.

Not verifiable as of 2026-08-29. No active Re7 Labs bug bounty program was confirmed in the gathered web results, and no program page with start date, scope, severity tiers, payout parameters, or disclosed findings was found. The only directly relevant materials located were Re7 Labs social posts and a third-party article about a 2026 USR incident compensation pool, which is remediation rather than a bug bounty program. If a bounty exists, its parameters and results are not verifiable from the available sources.

Custody is organized in a mixed model rather than a single arrangement. For some institutional strategies, Re7 uses third-party custodians: Re7 says its BTC Yield and Market Neutral strategies use Zodia Custody for segregated cold storage and on-chain representations of fund interests, and its mRe7ETH strategy has an Anchorage Digital qualified-custody integration for institutional ETH holders. For self-custody user flows, Re7 says deposits can originate from wallets such as TON Wallet, where users retain full self-custody while assets flow into Re7-curated vaults or the mRe7YIELD portfolio.

Re7 Labs does not publicly document a dedicated cryptographic key-management architecture on its own site in the material provided. The clearest available description is that Re7 Labs supports DeFi strategies with in-house risk tooling and research, while Re7 Capital describes it as the innovation arm behind curated vaults and risk management. For operational control, the public descriptions point to a *curator/advisor* model rather than a custody-first model: Re7 curates vaults, sets risk parameters, and actively monitors positions across protocols. However, the sources do not specify whether signing authority is centralized, multisig-based, MPC-based, hardware-wallet-based, or delegated through session keys for Re7 Labs itself. One adjacent source about a Re7 collaboration with Giza says institutional agents use modular smart accounts owned by the treasury and authorize transactions with time-bound session keys that can be revoked on-chain. Because that source describes Giza’s agent design, not Re7 Labs’ internal key policy, it can only be used as contextual evidence for how some Re7-related treasury operations may be organized—not as proof of Re7 Labs’ own key management. So the most defensible answer is: Not verifiable as of 2026-08-29 for the exact internal key-management setup of Re7 Labs. Public sources only support that Re7 Labs is the research/risk function behind institutional DeFi vault curation, with transaction/control details not disclosed.

Re7 Labs appears to be a technology / DeFi innovation arm of Re7 Capital, a London-based crypto investment firm, with a largely public leadership and a real off-chain business footprint, not just a web front. Founders & key people

• Multiple sources describe Evgeny Gokhberg as *founder of Re7 Capital* and *founder of Re7 Labs* / Re7.
• A podcast and press pieces present him as CEO / Managing Partner of Re7 Capital, overseeing ~$700–800M+ in DeFi AUM across >100 pools on ~14 chains (figures vary by source and date, so they should be treated as marketing-range, not on-chain verified).
• Pyth Network’s integration blog quotes a Re7 Labs representative “Royce, Re7 Labs”, implying at least one more named team member with public presence. Team, anonymity, and track record
• Re7 Labs is consistently described as the DeFi innovation / technology arm of Re7 Capital, which positions itself as an institutional DeFi investment and research firm.
• Careers and marketing copy emphasize “digital assets experts specialising in DeFi” and “founders & operators for 3 market cycles”, indicating a multi-cycle track record, though this is an *unverified marketing claim* absent independent performance or on-chain validation.
• Public interviews with Gokhberg on risk management and DeFi strategies suggest a non-anonymous leadership, with personal identity and voice attached to the brand.
• No independent evidence of major prior project hacks or catastrophic failures linked to Re7 Labs / Re7 Capital was found; absence of evidence is not proof of safety. Jurisdiction, office, and business reality
• Multiple sources frame Re7 Capital as London-based, with Re7 Labs as its technology arm, implying a UK-centric, likely onshore corporate base rather than a pure offshore shell, but detailed legal entity data is *not verifiable as of 2026-08-29*.
• The positioning as a hedge fund / investment firm managing hundreds of millions, plus partnerships with World Liberty Financial, Pyth Network, Gearbox, Midas/Wallet DeFi Account, supports the view that this is a real operating business with institutional counterparties, not just a standalone protocol website. Reality check / credibility flags
• Assets-under-management and TVL claims ("$550M", "$700M", "$800M", "$1B+ in DeFi capital") differ across sources and dates, and cannot be on-chain verified in this run; treat them as unverified marketing claims.
• No audited legal structure, regulator registrations, or office address could be confirmed from independent regulatory databases in this pass — Not verifiable as of 2026-08-29.
• Overall, leadership is public, the firm appears London-based with real B2B partnerships, but key risk facts (exact AUM/TVL, entity details, regulatory status) remain unverified and should be validated before institutional exposure.

Re7 Labs currently has a generally positive, institutional-facing reputation, with some criticisms around its communications in crisis situations but no public fraud, rug-pull, insolvency of Re7 itself, or regulatory/sanctions actions identified as of 2026‑08‑29. ### Team, parent firm, and positioning

• Re7 Labs is described as the innovation / risk curation arm of Re7 Capital, a London-based, research-driven digital asset investment firm focused on DeFi.
• Re7 Capital is reported to manage hundreds of millions in AUM (≈$300–800m) and to have been providing liquidity in DeFi since 2019, which contributes to an institutional image.
• Public branding emphasizes DeFi risk management, vault curation, and research, including proprietary risk tooling and a Re7 DeFi Ratings framework. ### Ecosystem role and external perception
• Multiple independent profiles (Alchemy, Portals, OurNetwork, MrDeFi) characterize Re7 Labs as a respected vault curator running curated lending/yield vaults on protocols like Morpho, Euler, Silo, Mellow, Gearbox across many chains, with tens to hundreds of millions in deposits/TVL.
• Re7 acts as a governance delegate and liquidity provider in ecosystems such as Morpho, reinforcing its image as an embedded, long-term DeFi participant.
• Social presence (X/Twitter) shows ongoing collaboration announcements with TAC, TON wallet, Morpho, etc., consistent with active ecosystem engagement rather than opportunistic yield farming. ### Criticisms, incidents, and crisis handling
• Coverage of the Stream Finance insolvency notes that Re7 Labs faced “significant heat” after publishing a long X thread with its own interpretation of events, which some parties criticized as self-serving or incomplete. This is a reputational mark around communications and perceived neutrality, not an allegation of Re7 misappropriating funds.
• In the Resolv Labs USR exploit, Re7’s users were impacted via its USDC vaults on Base and Ethereum; Re7 responded by opening a 223k USDC compensation pool for affected wallets, framed as a proactive remediation measure. This portrays Re7 as willing to absorb costs to protect users, which is positively perceived in The Defiant’s coverage. ### Legal, regulatory, and sanctions
• No public records in the reviewed material indicate regulatory enforcement, sanctions listings, fraud or rug-pull allegations specifically against Re7 Labs or Re7 Capital as of 2026‑08‑29. ### Unresolved concerns / monitoring points
• Re7’s business model concentrates strategy and risk decisions in a single curator across many chains and protocols, so operational, governance, and model risk are structurally high even if smart-contract risk is outsourced to host protocols.
• On-chain verification of TVL distribution per chain, real performance, and any undisclosed related-party flows: Not verifiable as of 2026‑08‑29.
• Communications in stress events (e.g., Stream Finance) remain a soft reputational vulnerability that institutional allocators should monitor.

Re7 Labs appears to be a multi-strategy yield / risk-managed DeFi asset manager rather than a single on-chain protocol with a clear, unified vault system. Its economic model is therefore only partially observable. Not verifiable as of 2026-08-29. ### 1. Strategy & Asset Flows

• Public materials describe Re7 as running systematic, market-neutral and directional strategies across DeFi, CeFi, and derivatives, focusing on yield, basis trades, and relative value, targeted at institutional LPs.
• Capital typically comes from whitelisted investors / funds, is deployed across heterogeneous venues (perps, options, money markets, LST/LRT, basis trades) and not into a single transparent vault contract.
• Detailed per-chain vault structures (World Chain, Plasma, Plume, etc.) are not documented in independent sources. Not verifiable as of 2026-08-29. ### 2. Yield Sources & Risk Profile
• Yield is primarily organic: funding-rate capture, spread / basis, options / volatility strategies, lending yields, and LST/LRT staking rewards.
• There is no evidence of large token-incentive programs or mercenary liquidity mining attached specifically to “Re7 Labs” products; any such claims would be unverified marketing claims.
• Strategies are *partly market-neutral* (basis / arbitrage, relative value) and *partly directional* (trend / momentum, convexity).
• Use of leverage is implied (perps, margin, options), but exact leverage bands, looping, restaking layers, or external rehypothecation are not disclosed quantitatively. Not verifiable as of 2026-08-29. ### 3. Lock-ups, Withdrawals, Collateral
• Institutional mandates usually include lock-up periods and notice windows; specific terms for Re7 vehicles are available only in investor docs / side letters, not public sources. Not verifiable as of 2026-08-29.
• Collateral is likely a mix of stablecoins, ETH/BTC, LSTs/LRTs, and major DeFi assets, but exact asset weights by chain are not independently documented. Not verifiable as of 2026-08-29. ### 4. Fees, Limits, Revenue
• As an asset manager, Re7 most likely operates on management + performance fees to LPs, rather than protocol-level swap / borrow fees; concrete fee grids are not public. Not verifiable as of 2026-08-29.
• Protocol-level revenue sharing, tokenholder fee capture, or buyback mechanics are not evidenced in independent sources. Not verifiable as of 2026-08-29. ### 5. TVL, APY, Per-Chain View
• There is no reliable DeFiLlama / public analytics listing for “Re7 Labs” with contract-level TVL by chain; any TVL figure would be an unverified marketing claim. Not verifiable as of 2026-08-29.
• APY history, volatility, and sustainability metrics for specific Re7 products are not available in public analytics or explorer-based dashboards. Not verifiable as of 2026-08-29. Overall: Re7 Labs functions more like an off-chain, discretionary/systematic DeFi hedge fund using DeFi venues rather than a transparent on-chain, retail protocol with inspectable TVL/APYs by chain and product.

Re7 Labs appears to be the same entity operating under re7labs.xyz and as the DeFi curator/allocator behind multiple vaults and strategies, but its treasury/reserve structure is not fully verifiable from the available sources. The only hard figures surfaced were AUM/TVL-like platform metrics: Re7-related dashboards and profiles show about $81.12M TVL on one aggregator, while a separate Re7-linked post claims ~$900M AUM and another claims vaults above $1B; these figures conflict and are not directly reconcilable here, so the on-chain or independently verified treasury size is Not verifiable as of 2026-08-29. The sources also indicate custody is primarily via user-deposited vaults and strategy contracts, with “full self-custody” language on the site/blog and multiple vault owners/timelock/guardian references on vault pages, but the actual treasury reserve addresses, signers, and control policy are Not verifiable as of 2026-08-29. Composition is partly inferable only at a high level from public materials: strategy/vault assets include BTC, ETH, USDT, eUSD, USD1, and other supported assets across World Chain, Avalanche, Plasma, Ethereum, Starknet, Binance, Plume Mainnet, and Linea, but per-chain reserve balances are Not verifiable as of 2026-08-29. No independent reserve attestation, proof-of-reserves report, or audited treasury statement was identified in the gathered web results, so reserve policy and attestation status remain Not verifiable as of 2026-08-29.

Re7 Labs’ BTC-< $10,000 stress outcome is not verifiable as of 2026-08-29 from the available sources. The search results confirm that Re7 Labs has publicly discussed real loss events and risk-mitigation actions around stablecoin-protocol collapses, including exposure on Plasma and WorldChain, but they do not provide a chain-by-chain balance sheet, collateral composition, leverage, or liquidation thresholds needed to model a BTC crash scenario. What can be said from the available evidence is limited: Re7 Labs describes itself as a research-driven digital asset firm focused on DeFi yield and liquid alpha strategies, which implies active risk management but not the size or structure of any BTC-linked exposure. The results also show that external media has covered prior Re7 Labs risk events, reinforcing that the protocol has faced loss-management situations, but those reports still do not quantify BTC sensitivity. Because on-chain verification is unavailable in this run, I cannot confirm whether a Bitcoin drop below $10,000 would trigger liquidations, bad debt, or redemptions on any of the listed chains (World Chain, Avalanche, Plasma, Ethereum, Starknet, Binance, Plume Mainnet, Linea). Any specific numeric impact would be speculation. Most relevant risk interpretation: a BTC crash to below $10,000 would likely increase stress on any strategy using BTC as collateral, BTC-pegged assets, or correlated risk assets, but the magnitude and transmission path are not verifiable from the provided sources.

A 20% depeg in the largest collateral would be a severe tail-risk event for Re7 Labs, but the exact loss cannot be quantified from the available results. Re7’s own incident updates show that the protocol has already faced multi-market losses tied to stablecoin collateral failures, including about $13.114M from Stable Labs and about $13.974M from the Stream/Elixir side, with affected markets spanning Euler, Morpho, and Plume; however, the current exposure set for the specified chains is not fully verifiable from the provided web results. What can be stated with confidence is that a 20% collateral drop is a standard stress level that can push leveraged positions below liquidation thresholds and create bad debt if liquidations cannot clear fast enough; this is the mechanism described in a banking risk paper and in DeFi depeg simulations such as Chaos Labs’ stETH case study. For Re7 Labs specifically, the available material indicates concentrated exposure to stablecoin-collateralized markets and prior risk-mitigation actions such as cap reductions, borrowing freezes, and withdrawals from affected markets, but it does not provide a complete, chain-by-chain balance sheet for World Chain, Avalanche, Plasma, Ethereum, Starknet, Binance, Plume Mainnet, or Linea. Therefore, the maximum-loss estimate under a 20% depeg is Not verifiable as of 2026-08-29 from the supplied sources. Key risk implication: if the largest accepted collateral is also the most widely reused across Re7-curated markets, a 20% depeg could cause simultaneous liquidations across multiple venues and chains, making realized loss depend more on oracle speed, liquidity depth, and exit timing than on the depeg itself.

Re7 Labs is primarily a vault curator on top of lending and structured-yield protocols (Morpho, Euler, Silo, Mellow, Gearbox, etc.), not a stand‑alone lender. This means the “top counterparty” in a stress event is usually an *underlying lending pool borrower/LP* or an *upstream protocol* rather than Re7 itself. Below is a generic institutional stress path for “top counterparty becomes insolvent”, tailored to Re7‑style vaults. On‑chain verification is Not verifiable as of 2026‑08‑29. ### 1. Borrower insolvency in an underlying lending market Trigger Largest borrower in a Morpho / Euler / Silo market used by a Re7‑curated vault defaults (collateral value < debt, cannot be liquidated fully). Expected loss path

• The loss is first realized at the underlying protocol pool level (e.g., Morpho market bad debt).
• That bad debt reduces the pool’s asset value, so the ERC‑4626 vault’s share price / asset per share falls. Who absorbs it?
• Vault depositors in the affected Re7 vault (mRe7YIELD holders, curated MetaMorpho vault LPs, etc.) via a lower share price or reduced redeemable assets.
• Other lenders in the same underlying pool (non‑Re7 depositors) absorb proportional losses.
• Re7 Labs itself typically does *not* act as a guarantor; its role is the strategy/risk curator, not the balance‑sheet backstop. Compensation / recovery
• Primary “compensation” is via liquidations of the defaulting borrower and any protocol‑specific safety modules or insurance funds (if present; design is protocol‑dependent, not Re7‑specific).
• Any shortfall beyond what liquidations and safety modules cover remains uncompensated and is borne by lenders (including Re7 vault depositors). Impact through smart contracts
• Underlying market’s accounting contracts mark down total assets (post‑liquidation).
• The ERC‑4626 vault contract reads updated balances and re‑prices vault shares, so redemptions return fewer assets per share.
• If there is a wrapper token (e.g., mRe7YIELD on Midas / wallets), its on‑chain exchange rate to the base asset reflects the loss.
• Cross‑chain: each chain’s vault is economically siloed; an insolvency on Avalanche or Ethereum does *not* auto‑drain other chains, but aggregated AUM and firm‑level risk are impacted. ### 2. Upstream protocol‑level failure (systemic counterparty) Trigger A major underlying protocol (e.g., Morpho, Gearbox, Mellow) suffers oracle failure, governance hack, or systemic exploit affecting all markets. Expected loss path
• Protocol‑wide impairment of assets or governance seizure; vault assets can be frozen, mispriced, or stolen. Who absorbs it?
• Again, vault depositors and other protocol LPs bear direct economic loss.
• Any protocol‑specific insurance/safety module stakers (if present) may also be slashed before lenders. Compensation / impact path
• Recovery only via that protocol’s emergency procedures (guardians, pausing, migration to new contracts).
• ERC‑4626 vaults may be upgraded or migrated to new underlying markets, but losses already crystallized in the old pool remain. Across World Chain, Avalanche, Plasma, Ethereum, Starknet, BSC, Plume, and Linea, this logic repeats per‑chain; losses remain local to the chain and vault where the insolvent counterparty sits, with no explicit firm‑wide guarantee identified.

For a stress scenario of committed fraud by the DAO or owners, I found no verifiable evidence that Re7 Labs’ DAO or owners were found to have committed fraud. The available reporting instead describes risk-management disputes, governance actions, and alleged misconduct by external counterparties around vault incidents, while Re7 Labs publicly denies wrongdoing in response to allegations. What *is* supported by the record is that Re7 Labs faced criticism over the handling of incidents tied to Stream, Elixir, Stable Labs/USDX, and related vault exposure, including claims of delayed response, parameter-setting issues, and communication failures. Those sources do not establish fraud by the DAO or owners; they establish controversy and alleged negligence/operational failure at most. If you need a strict diligence classification for this stress case, the correct status is: Not verifiable as of 2026-08-29. Relevant nuance:

• Re7 Labs itself said its strategy had no exposure to certain exploits and described specific attack mechanics in incident updates, which is a defensive operational position rather than an admission of fraud.
• Media coverage about vault failures and accountability disputes is not equivalent to a legal finding of fraud.

Re7 Labs’ primary yield source is not verifiable as of 2026-08-29, and I cannot confirm a specific 30-day negative-yield scenario from the available web results alone. The most relevant public evidence indicates Re7 Labs runs tokenized yield strategies such as mRe7YIELD, with returns generated from a mix of liquidity provision, lending, restaking, and arbitrage; the wallet documentation explicitly says returns are variable and may be materially lower or negative. For stress testing, the clearest supported takeaway is that downside is plausible if the strategy’s underlying DeFi legs underperform, funding/borrow costs rise, or collateral positions suffer impairment. Re7’s own ETH strategy description says it uses a market-neutral leveraged staking loop, which can be exposed to spread compression and adverse market conditions. DefiLlama shows Re7 Labs’ curated vault activity but does not break out a verified “primary yield source” or a chain-by-chain 30d yield attribution in the provided result set. The strongest negative-performance signal in the results is historical, not a verified current 30d metric: third-party coverage reports Re7 Labs had meaningful bad debt/exposure in the Stream Finance / depeg episode, indicating that yield strategies tied to illiquid or depegged collateral can produce losses under stress. However, that does not prove the last 30 days were negative, only that the protocol has faced material stress before. If you need an institutional-grade answer, the current evidence supports only this conservative statement: negative 30d primary-yield performance is possible, but not verifiable from the supplied sources. The exact 30d yield, per chain or per product, is Not verifiable as of 2026-08-29.

Re7 Labs appears to be company‑controlled infrastructure with investor‑style governance, not a user DAO. However, on‑chain voting, timelocks, and signer details are Not verifiable as of 2026‑08‑29. ### 1. Who controls dev / contracts / frontend / funds

• Public materials describe Re7 as a “decentralized asset management protocol” operated by Re7 Labs, an investment/infra team, not a community DAO.
• Smart‑contract ownership (admin addresses, upgradeability, timelocks, multisigs) and custody of protocol funds cannot be confirmed from web sources alone without Dune/on‑chain inspection. Not verifiable as of 2026‑08‑29.
• Frontend (re7labs.xyz app) is developed and hosted by Re7 Labs; no evidence of a separate DAO‑controlled frontend. ### 2. Governance / DAO vs. company
• No clear, detailed on‑chain governance framework (e.g., Snapshot, Governor contracts, proposal lifecycle) is documented in independent sources.
• No evidence of a functioning token‑holder DAO with binding power over contracts or treasury decisions; governance appears symbolic or informal, centered on the core team and investors rather than a formal DAO.
• Any mentions of “community” or “decentralization” are marketing language without independent verification, so they are unverified marketing claims. ### 3. Token, voting concentration & top holders
• Existence of a governance token, its ticker, supply schedule, and voting mechanics cannot be independently established from non‑protocol sources. Not verifiable as of 2026‑08‑29.
• Distribution (top holders, vote concentration, % controlled by team/investors, chain‑by‑chain breakdown) requires on‑chain/Dune analysis, which is unavailable. Not verifiable as of 2026‑08‑29. ### 4. Timelocks, multisigs, signers, powers
• No independent disclosures of:
• Admin timelocks for upgrades
• Multisig addresses, signer count/threshold, or identities
• Separation between ops/treasury/security multisigs
• Explicit scopes (e.g., ability to pause, upgrade, move funds) All of the above are Not verifiable as of 2026‑08‑29. ### 5. Legal entity, jurisdiction, ToS
• Re7 Labs is described in media/partnership materials as an investment / asset‑management technology company, but without a publicly cited legal entity registry entry (name, jurisdiction, registration number, directors).
• The app/site does not expose a clearly labeled Terms of Service or legal imprint in independent coverage; any ToS details are Not verifiable as of 2026‑08‑29. ### 6. Risk takeaway From a governance‑risk perspective, Re7 today should be treated as core‑team / company‑controlled, with opaque control structure and no independently verifiable DAO governance or on‑chain checks and balances across the listed chains.

Re7 Labs appears to be a DeFi yield protocol / asset manager operating across multiple chains, but almost all legal/regulatory signals must be treated as unverified marketing claims or "Not verifiable as of [2026-08-29]" due to limited public documentation. ### 1. Entity, jurisdiction, legal structure

• Public sources mention Re7 Labs as a crypto-native asset manager and yield protocol, but do not clearly state a registered legal entity name, jurisdiction, or company number.
• No independently verifiable corporate registry entry (e.g., UK, EU, US, offshore) could be matched to the protocol with high confidence.
• Not verifiable as of 2026-08-29.
• Any LLC/foundation/DAO structure described only on their own site would be an unverified marketing claim. ### 2. Terms of Service, user restrictions
• I could not locate a separately hosted Terms of Service, User Agreement, or Risk Disclosure document via independent sources.
• No clear statement on geographic restrictions (e.g., US persons, sanctioned jurisdictions) is visible in third‑party materials.
• Not verifiable as of 2026-08-29. ### 3. KYC / AML, compliance posture
• No credible independent evidence that Re7 Labs operates with KYC/AML onboarding similar to a regulated fund or broker.
• No indication in public compliance registries that it is licensed as an investment firm, AIFM, broker-dealer, or VASP.
• Not verifiable as of 2026-08-29. ### 4. Regulatory classification and registrations
• No record found in major regulator databases (SEC, FCA, ESMA/NCA, MAS, etc.) linking Re7 Labs to a registered or authorized entity.
• Not verifiable as of 2026-08-29.
• From an institutional risk lens, Re7 Labs should be treated as an unregulated DeFi protocol / crypto-native asset manager, pending direct confirmation. ### 5. Warnings, enforcement, court cases, sanctions
• No official regulatory warnings, enforcement actions, or court cases identified in mainstream legal/crypto news databases referencing Re7 Labs.
• Absence of evidence is not evidence of absence; it only means no public record found.
• No listing in major sanctions databases (OFAC, EU, UN) tying the name to a designated person or entity.
• Not verifiable as of 2026-08-29. ### 6. Data protection / privacy
• No independent documentation of privacy policy, data-controller identity, or GDPR/CCPA posture.
• Any policy on their own site would be an unverified marketing claim. ### 7. Key institutional risk takeaway For institutional use, Re7 Labs currently screens as a non‑transparent, likely unregulated DeFi protocol with unclear legal entity, licensing, KYC/AML, and jurisdictional status, requiring direct DDQ/engagement before any exposure.

The stablecoin depeg associated with Re7 Labs appears to have happened at least once: the clearest confirmed incident in the retrieved material is the xUSD de-peg reported on 2025-11-09, with Re7 Labs saying it impacted over $13 million in funds. How many times: Not verifiable as of 2026-08-29. The available results point to one clearly documented depeg incident affecting Re7 Labs exposure (xUSD), plus separate references to other stablecoin stress events in related vaults, but they do not establish a complete count of every depeg event tied to the protocol. Last time: 2025-11-09 is the latest clearly identified depeg-related report in the retrieved sources. Depeg %: Not verifiable as of 2026-08-29. The retrieved sources describe dollar losses and affected funds, but they do not provide a single authoritative percentage depeg figure for the Re7 Labs incident.

Re7 Labs’ top risks are concentrated in curator/investment decision risk, cross-protocol contagion, stablecoin and collateral depeg risk, smart-contract/oracle risk, and operational/governance concentration risk. The strongest evidence in the provided material is the reported Stream Finance collapse, which exposed Re7 Labs to about $27.4M in bad debt across Euler and Morpho vaults, showing that its risk framework can miss circular collateral structures and oracle lag risk.

• Curator decision risk: Re7 Labs appears to make centralized collateral-allocation decisions, so poor asset selection can directly translate into losses.
• Cross-protocol contagion: the same collateral is deployed across multiple venues, so a problem in one market can spread across the rest of the portfolio.
• Stablecoin / collateral depeg risk: the cited Stream-related losses involved illiquid or depegged stablecoin collateral, which can rapidly create bad debt.
• Smart-contract and oracle risk: Re7’s own research highlights smart-contract bugs, reentrancy, inflated-collateral attacks, and oracle-related failure modes as core DeFi risks.
• Operational / governance concentration risk: reliance on specific operators, timelocked multisig control, and institutional execution creates delay, coordination, and accountability risk, especially during fast market stress. I could not verify on-chain exposure by chain in this run, so chain-level risk splits are Not verifiable as of 2026-08-29.

Re7 Labs’ top strengths are: institutional risk curation, with its core positioning centered on professional vault and market risk management for DeFi yield strategies; multi-protocol and multi-chain reach, with reported deployment across major venues such as Morpho, Euler, Silo, Mellow, Symbiotic, Gearbox, and Midas, spanning multiple chains; proprietary analytics, including its in-house Re7 Risk Index and blockchain monitoring/anomaly-detection tooling used to guide vault allocation decisions; restaking and oracle sophistication, combining restaking-related structures with Pyth and Oval/UMA-style oracle tooling to improve pricing robustness on some vaults; and scale and market credibility, with third-party descriptions citing roughly $700M-$800M+ TVL/AUM and a multi-year operating track record in DeFi.